Iavarone A, Lasorella A (2004) Id proteins in neural cancer.
Cancer Lett 204:189-196 Ichikawa M, Murakumo Y, Takahashi M (2004) RET and neuroendocrine tumors. Cancer Lett 204:197-211 Ichimiya S et al (1999) p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18:1061-1066 Ichimiya S, Nimura Y, Seki N, Ozaki T, Nagase T, Nakagawara A (2001) Down-regulation of hASHi is associated with the retinoic acid-induced differentiation of human neuroblas-toma cell lines. Med Pediatr Oncol 36:132-134 Ikeda H et al. (1995) Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J Pediatr Surg 30:805-808 Ikegaki N, Katsumata M, Tsujimoto Y, Nakagawara A, Brodeur GM (1995) Relationship between bcl-2 and MYC gene expression in human neuroblastoma. Cancer Lett 91:161168
Islam A et al (2000) High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19:617-623 Kadomatsu K, Muramatsu T (2004) Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204:127143
Kadomatsu K, Huang R-P, Suganuma T, Murata F, Muramatsu T (1990) A retinoic acid responsive gene MK found in the ter-atocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol 110:607-616
Kawamoto T, Ohira M, Hamano S, Hori T,Nakagawara A (2003) High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta is associated with favorable prognosis in human neuroblastomas. Int J Oncol 22:815-822 Kitanaka C et al (2002) Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression. J Natl Cancer Inst 94:358-368 Klein R (1994) Role of neurotrophins in mouse neuronal development. FASEB J 8:738-744 Klesse LJ, Parada LF (1999) Trks: signal transduction and in-
tracellular pathways. Microsc Res Tech 45:210-216 Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H (1993) Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res
Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A (2000) Id2 is a retinoblastoma protein target and mediates signalling by MYC oncoproteins. Nature 407:592-598 Laurenzi VD et al. (2000) Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem 275: 15226-15231
Li Y-S et al. (1990) Cloning and expression of a developmental-ly regulated protein that induces mitogenic and neurite outgrowth activity. Science 250:1690-1694 Lo L, Morin X, Brunet JF, Anderson DJ (1999) Specification of neurotransmitter identity by Phox2 proteins in neural crest stem cells. Neuron 22:693-705 Mac SM, D'Cunha CA, Farnham PJ (2000) Direct recruitment of N-MYC to target gene promoters. Mol Carcinogr 29: 76-86
Massari ME, Murre C (2000) Helix-loop-helix proteins: regulators of transcription in eukaryotic organisms. Mol Cell Biol
Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55:1798-1806 Moll UM, LaQuaglia M, Benard J, Riou G (1995) Wild-type p53 protein undergoes cytoplasmic sequestration in undiffer-entiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92:4407-4411 Morin X, Cremer H, Hirsch MR, Kapur RP, Goridis C, Brunet JF (1997) Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron 18:411-423 Nakagawa T et al (2002) Autoinhibitory regulation of p73 by ANp73 to modulate cell survival and death through p73-specific target element within the ANp73 promoter. Mol Cell Biol 22:2575-2585 Nakagawara A (1998a) The NGF story and neuroblastoma. Med Pediatr Oncol 31:113-115
Nakagawara A (1998b) Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 11:115-124 Nakagawara A (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett
Nakagawara A (2004) Neural crest development and neuroblastoma: the genetic and biological link. In: Aloe L, Calza L (eds) NGF and related molecules in health and disease. Elsevier,Amsterdam, pp 233-242 Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM (1992) Inverse relationship between trk expression and N-MYC amplification in human neuroblastomas. Cancer Res 52:1364-1368
Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854 Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM (1994) Expression and function of TRK-B and BDNF in human neu-roblastomas. Mol Cell Biol 14:759-767 Nakagawara A et al. (1995) Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 55:1792-1797 Nakagawara A et al. (1997) High levels of expression and nuclear localization of ICE and CPP32 in favorable human neuroblastomas. Cancer Res 57:4578-4584 Nakamura Y, Ozaki T, Koseki H, Nakagawara A, Sakiyama S (2003) Accumulation of p27KIFl is associated with BMP2-mediated growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines. Biochem Biophys Res Commun 307:206-213 Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501 Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF (1999) The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399:366-370 Pozniak CD, Radinovic S,Yang A, McKeon F, Kaplan DR, Miller FD (2000) An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289:304-306
Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3:756-767 Reale MA et al. (1996) Loss of DCC expression in neuroblas-toma is associated with disease dissemination. Clin Cancer Res 2:1097-1102
Rodriguez-Leon J, Merino R, Macias D, Ganan Y, Santesteban E, Hurle JM (1999) Retinoic acid regulates programmed cell death through BMP signalling. Nat Cell Biol 1:125-126 Schneider C, Wicht H, Enderich J, Wegner M, Rohrer H (1999) Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons. Neuron 24:861-870 Schwab M et al. (1983) Amplified DNA with limited homology to MYC cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245-248
Schwab M et al (1984) Chromosome localization in normal human cells and neuroblastomas of a gene related to c-MYC. Nature 308:288-291 Schwab M et al. (2003) Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 4:472-480 Schweigerer L, Ledoux D, Fleischmann G, Barritault D (1991) Enhanced MYCN oncogene expression in human neuro-blastoma cells is associated with altered FGF receptor expression and cellular growth response to basic FGF. Bio-chem Biophys Res Commun 179:1449-1454 Seeger RC et al. (1985) Association of multiple copies of the N-MYC oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116 Shinbo J et al. (2002) p73-dependent expression of DAN during cisplatin-induced cell death and osteoblast differentiation. Biochem Biophys Res Commun 295:501-507 Snider WD (1994) Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-638 Soderholm H et al. (1999) Human achaete-scute homologue 1 (HASH-1) is downregulated in differentiating neuroblas-toma cells. Biochem Biophys Res Commun 256:557-563 Stanke M, Junghans D, Geissen M, Goridis C, Ernsberger U, Rohrer H (1999) The Phox2 homeodomain proteins are sufficient to promote the development of sympathetic neurons. Development 126:4087-4094 Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC (1993) Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:377-384 Teitz T et al (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6:529-535
Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12:3320-3324 Trochet D et al (2004) Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am J Hum Genet 74:761-764 Tweddle DA, Malcolm AJ, Bown N, Pearson AD, Lunec J (2001) Evidence for the development of p53 mutations after cyto-toxic therapy in a neuroblastoma cell line. Cancer Res 61:8-13
Van Noesel MM, Pieters R, Voute PA,Versteeg R (2003) The N-MYC paradox: N-MYC overexpression in neuroblastomas is associated with sensitivity as well as resistance to apopto-sis. Cancer Lett 197:165-172 Yamashiro D, Nakagawara A, Ikegaki N, Liu X, Brodeur GM (1996) Expression of TRK-C in favorable human neuroblas-tomas. Oncogene 12:37-41 Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103 Yano H, Cong F, Birge RB, Goff SP, Chao MV (2000) Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J Neurosci Res 59:356-364 Yoshida I, Koide S, Nakagawara A, Tsuji A, Matsuda Y (2001) Proprotein convertase PACE4 is a target gene of the basic helix-loop-helix transcription factor hASH-1. Biochem J 360:683-689
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.